solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
Gene Summary
Enables dopamine binding activity; dopamine:sodium symporter activity; and neurotransmitter transmembrane transporter activity. Involved in dopamine uptake; hyaloid vascular plexus regression; and neurotransmitter uptake. Acts upstream of or within several processes, including dopamine metabolic process; lactation; and prepulse inhibition. Located in axon terminus and cell surface. Is expressed in genitourinary system; nervous system; spleen; and submandibular gland. Used to study Gilles de la Tourette syndrome; attention deficit hyperactivity disorder; and schizophrenia. Human ortholog(s) of this gene implicated in attention deficit hyperactivity disorder; classic dopamine transporter deficiency syndrome; mild cognitive impairment; nicotine dependence; and obesity. Orthologous to human SLC6A3 (solute carrier family 6 member 3). [provided by Alliance of Genome Resources, Jul 2025]
Alternative Names
DA transporter antibody DAT 1 antibody DAT antibody DAT1 antibody Dopamine transporter 1 antibody Dopamine transporter antibody PKDYS antibody SC6A3_HUMAN antibody SLC6A3 antibody Sodium dependent dopamine transporter antibody DA transporter antibody DAT 1 antibody DAT antibody DAT1 antibody Dopamine transporter 1 antibody Dopamine transporter antibody PKDYS antibody SC6A3_HUMAN antibody SLC6A3 antibody Sodium dependent dopamine transporter antibody Sodium-dependent dopamine transporter antibody Solute carrier family 6 (neurotransmitter transporter dopamine) member 3 antibody Solute carrier family 6 (neurotransmitter transporter) member 3 antibody Solute carrier family 6 member 3 antibody Variable number tandem repeat (VNTR) antibody